Effect of yoga on health-related quality of life in central nervous system disorders: A systematic review.

Dementia Epilepsy Multiple Sclerosis Parkinson’s disease Stroke

Journal

Clinical rehabilitation
ISSN: 1477-0873
Titre abrégé: Clin Rehabil
Pays: England
ID NLM: 8802181

Informations de publication

Date de publication:
Nov 2021
Historique:
pubmed: 1 6 2021
medline: 21 10 2021
entrez: 31 5 2021
Statut: ppublish

Résumé

Investigate the effect of yoga on health-related quality of life (HRQoL) in patients with central nervous system disorders. A systematic search was conducted on the PubMed-NCBI, EBSCO Host, Cochrane Library, Scopus and ScienceDirect databases until 05 April 2021. Only randomized control trials published in English or French were included and had to compare yoga to another intervention group or a control group. They also had to clearly measure HRQoL. Methodological quality was assessed with the revised Cochrane risk-of-bias tool for randomized trials and the quality of evidence was evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria. Sixteen studies were found, including six for multiple sclerosis, five for Parkinson's disease, two for stroke, one for dementia, one for epilepsy and one for brain tumour. Only 12 studies performed between-group statistics and 8 found a significant difference between groups after treatment. When yoga was compared to no intervention, the results were generally in favour of the yoga group, but when yoga was compared to another intervention programme, there was generally no significant difference between groups. There were many different HRQoL questionnaires, even within the same disease, which reduces the comparability of studies. With low to moderate quality of the evidence, yoga seems effective to improve HRQoL in people with Parkinson's disease. For multiple sclerosis, stroke, dementia, epilepsy and brain tumour, the quality of the evidence is still insufficient to conclude of the effectiveness of yoga.

Identifiants

pubmed: 34053238
doi: 10.1177/02692155211018429
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1530-1543

Auteurs

Rita Lenoir Dit Caron (R)

CETAPS Laboratory, EA 3882, Rouen University, Mont Saint Aignan, France.
Clinical Research Department, La Musse Hospital (Fondation La Renaissance Sanitaire), Saint-Sébastien-de-Morsent, France.

Jeremy Coquart (J)

CETAPS Laboratory, EA 3882, Rouen University, Mont Saint Aignan, France.

Maxime Gilliaux (M)

CETAPS Laboratory, EA 3882, Rouen University, Mont Saint Aignan, France.
Clinical Research Department, La Musse Hospital (Fondation La Renaissance Sanitaire), Saint-Sébastien-de-Morsent, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH